Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05842330 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Benefits of ADHD Treatment in Detained People

Study acronym: BATIR
StatusRecruiting
PhasePhase 3
Started2024-01-01
View on ClinicalTrials.gov ↗
Attention deficit hyperactivity disorder (ADHD) is characterized by difficulties paying attention, poor impulse control, and hyperactive behaviors. It is associated with several health and social detrimental outcomes and leads to increased risks of criminality and recidivism. However, to date, ADHD treatment has been neglected in prison. This project will test the efficacy of ADHD treatment using a randomized controlled trial.

Amendment record

Amended 5 times since 2023-04-22; most recent filed 2026-03-13. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-31.

2026-03-13
Amendment Study Status, Oversight, Study Design, Contacts/Locations v5
2025-06-29
Amendment Study Identification, Study Status, Eligibility, IPDSharing v4
2024-10-07
Amendment Study Identification, Study Status, Oversight, Study Description, Study Design, Outcome Measures, Eligibility, Contacts/Locations v3
2024-04-18
Amendment Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
2023-11-28
Amendment Study Status, Study Description, Outcome Measures v1
2023-04-22
Original filing
Trial Details
NCT Number NCT05842330
Lead Sponsor Stéphanie Baggio
Collaborators: University of Lausanne, University of Geneva, Switzerland, Netherlands Institute for the Study of Crime and Law Enforcement, School of Health Sciences Fribourg
Conditions ADHD
Enrollment 150 participants
Start Date 2024-01-01
Primary Completion 2026-10-30 (estimated)
Study Completion 2027-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-17